| |
Model 1
|
Model 2
|
Model 3
|
Model 4
|
|---|
| |
B
|
Pvalue
|
B
|
Pvalue
|
B
|
Pvalue
|
B
|
Pvalue
|
|---|
|
Age (years)
|
0.057
|
0.122
|
0.064
|
0.081
|
0.032
|
0.314
|
0.055
|
0.103
|
|
Gender (male)
|
0.738
|
0.108
|
0.098
|
0.823
|
-0.228
|
0.575
|
-0.435
|
0.292
|
|
Years of education
|
-0.583
|
0.011
|
-0.333
|
0.105
|
-0.266
|
0.181
|
-0.190
|
0.318
|
|
Student (yes)
|
-1.261
|
0.083
|
0.587
|
0.365
|
-0.805
|
0.203
|
-0.455
|
0.449
|
|
Employment (yes)
|
-1.068
|
0.078
|
-1.099
|
0.043
|
-0.638
|
0.225
|
-0.798
|
0.112
|
|
Married (yes)
|
0.174
|
0.788
|
0.168
|
0.769
|
0.010
|
0.985
|
0.011
|
0.984
|
|
ESR
| | |
0.007
|
0.535
| | |
0.009
|
0.399
|
|
CRP
| | |
-0.005
|
0.941
| | |
-0.022
|
0.706
|
|
Disease duration
| | |
-0.055
|
0.230
| | |
-0.052
|
0.214
|
|
Morning stiffness (minute)
| | |
0.001
|
0.919
| | |
0.001
|
0.904
|
|
Fingertip-to-floor distance (cm)
| | |
-0.011
|
0.481
| | |
-0.009
|
0.531
|
|
Overall assessment of health (VAS)
| | |
0.029
|
0.760
| | |
-0.039
|
0.658
|
|
Nocturnal pain (VAS)
| | |
0.267
|
0.012
| | |
0.258
|
0.009
|
|
Total back pain (VAS)
| | |
0.133
|
0.302
| | |
0.168
|
0.159
|
|
BASMI
| | |
-0.222
|
0.100
| | |
-0.149
|
0.233
|
|
BASDAI (VAS)
| | |
0.456
|
0.005
| | |
0.210
|
0.168
|
|
BASFI (VAS)
| | |
-0.067
|
0.595
| | |
-0.157
|
0.184
|
|
SDS
| | | | |
0.064
|
0.004
|
0.059
|
0.008
|
|
SAS
| | | | |
0.170
|
0.000
|
0.120
|
0.000
|
|
R2 (%)
|
8.5
| |
32.0
| |
32.4
| |
42.6
| |
|
Adjusted R2 (%)
|
6.7
| |
28.0
| |
30.6
| |
38.9
| |
- Model 1 F = 4.756; P = 0.000; Model 2 F = 8.176; P = 0.000; Model 3 F = 18.290; P = 0.000; Model 4 F = 11.507; P = 0.000. BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath Ankylosing Spondylitis Functional Index; BASMI, Bath Ankylosing Spondylitis Metrology Index; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; PSQI, Pittsburgh Sleep Quality Index; SAS, Self-rating Anxiety Scale; SDS, Self-rating Depression Scale; VAS, visual analogue scale.
